Novo advances next-gen amycretin program after promising weight-loss, blood sugar data - Reuters

Reuters | Nov. 25, 2025, 11:55 a.m. | Original
Novo advances next-gen amycretin program after promising weight-loss, blood sugar data Reuters
Japan fires back at 'unsubstantiated' Chinese letter to UN - Reuters Flughafen Wien Says Project For 3rd Runway Will Not Be Continued - TradingView